Background With over a hundred million annual infections and rising morbidity and mortality,
Plasmodium vivax malaria remains largely a neglected disease. In particular, the …

Background Plasmodium vivax has the widest geographic distribution of the human malaria
parasites and nearly 2.5 billion people live at risk of infection. The control of P. vivax in …

Plasmodium vivax and Plasmodium ovale form dormant liver hypnozoites that can reactivate
weeks to months following initial infection. Malaria recurrences caused by relapses are an …

Background In malaria endemic populations, complex patterns of Plasmodium vivax and
Plasmodium falciparum blood-stage infection dynamics may be observed. Genotyping …

Plasmodium vivax poses unique challenges for malaria control and elimination, notably the
potential for relapses to maintain transmission in the face of drug-based treatment and …

Historically, malaria in India was predominantly caused by Plasmodium vivax, accounting for
53% of the estimated cases. After the spread of drug-resistant Plasmodium falciparum in the …

Background Control of vivax malaria in endemic areas requires management of recurrence.
The Brazilian National Malaria Surveillance System (SIVEP-Malária) records every case of …

Recent autochthonous transmission of Plasmodium vivax malaria in previously malaria-free
temperate regions has generated renewed interest in the epidemiology of this disease …

Background Plasmodium vivax is the main cause of malaria in Nepal. Relapse patterns
have not been characterized previously. Methods Patients with P. vivax malaria were …

Several temperate countries have used mass chemoprevention interventions with medicines
of the 8-aminoquinoline class that prevent relapses from Plasmodium vivax before peak …